A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
In this study, we demonstrate the use of kinematic gait analysis based on ventral plane imaging to monitor the subtle changes in motor coordination as well as the progression of neurodegeneration with advancing age in mouse models (e.g., endophilin mutant mouse lines).
Motor behavior tests are commonly used to determine the functional relevance of a rodent model and to test newly developed treatments in these animals. Specifically, gait analysis allows recapturing disease relevant phenotypes that are observed in human patients, especially in neurodegenerative diseases that affect motor abilities such as Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and others. In early studies along this line, the measurement of gait parameters was laborious and depended on factors that were hard to control (e.g., running speed, continuous running). The development of ventral plane imaging (VPI) systems made it feasible to perform gait analysis at a large scale, making this method a useful tool for the assessment of motor behavior in rodents. Here, we present an in-depth protocol of how to use kinematic gait analysis to examine the age-dependent progression of motor deficits in mouse models of neurodegeneration; mouse lines with decreased levels of endophilin, in which neurodegenerative damage progressively increases with age, are used as an example.
Neurodegenerative diseases impose a significant burden on patients, families, and society, and will become of even greater concern as life expectancy increases, and the world population continues to age. One of the most common symptoms of neurodegenerative diseases are balance and mobility problems. Thus, characterization of motor behavior in aging mammalian (e.g., rodent) models, and/or models showing neurodegenerative phenotypes, is a valuable tool to demonstrate the in vivo relevance of the specific animal model(s), or therapeutic treatments that aim to improve the disease symptoms. Almost every approach to treat neurodegenerative diseases ultimately requires testing in an animal model before initiation of a clinical trial in humans. Therefore, it is crucial to have reliable, reproducible behavior tests that can be used to consistently quantify disease-relevant phenotypes along age progression, in order to ensure that a candidate drug, which showed potential in an in vitro model, can effectively ameliorate the phenotype in a living animal.
One aspect of motor behavior assessment in rodents is kinematic gait analysis, which can be performed by VPI (also called ventral plane videography)1,2. This established method capitalizes on continuous recording of the underside of the rodents walking atop a transparent and motorized treadmill belt1,2,3,4. Analysis of the video feed data creates "digital paw prints" of all four limbs that dynamically and reliably recapitulate the rodent's walking pattern, as originally described by Kale et al.2 and Amende et al.3.
The principle of imaging-based gait analysis is to measure the paw area in contact with the treadmill belt over time, for each individual paw. Every stance is represented by an increase in paw area (in the braking phase) and a decrease in paw area (in the propulsion phase). This is followed by the swing phase in which no signal is detected. Swing and stance together form a stride. In addition to gait dynamics parameters, posture parameters can also be extracted from the recorded videos. Exemplary parameters and their definition are listed in Table 1 and include stance width (SW; the combined distance from the fore or hind paws to the snout-tail axis), stride length (SL; average distance between two strides of the same paw), or paw placement angle (the angle of the paw to the snout-tail axis). The posture and gait dynamics data allow drawing conclusions on animal balance (by posture parameters and their variability over several steps) and coordination (by gait dynamics parameters). Other parameters, such as ataxia coefficient (the SL variability calculated by [(max. SL−min. SL)/mean SL]), hind limb shared stance time (time that both hind limbs are in contact with the belt), or paw drag (total area of the paw on the belt from full stance to paw lift-off) can also be extracted, and have been reported to be changed in various neurodegenerative disease models5,6,7,8 (see Table 1).
Parameter | Unit | Definition |
swing time | ms | duration of time the paw is not in contact with the belt |
stance time | ms | duration of time the paw is in contact with the belt |
% brake | % of stance time | percentage of stance time the paws are in the brake phase |
% propel | % of stance time | percentage of stance time the paws are in the propulsion phase |
stance width | cm | combined distance from the fore or hind paws to the snout-tail axis |
stride length | cm | average distance between two strides of the same paw |
stride frequency | strides/s | number of complete strides per second |
paw placement angle | deg | angle of the paw in relation to the snout-tail axis of the animal |
ataxia coefficient | a.u. | SL variability calculated by [(max SL-min SL)/mean SL] |
% shared stance | % of stance | hind limb shared stance time; time that both hind limbs are in contact with the belt at the same time |
paw drag | mm2 | total area of the paw on the belt from full stance to paw lift-off |
limb loading | cm2 | MAX dA/dT; maximal rate of change of paw area in the breaking phase |
step angle variability | deg | standard deviation of the angle between the hind paws as a function of SL and SW |
Table 1. Definition of key gait parameters that can be tested by ventral plane imaging.
Assessing the motor behavior of rodent models for neurodegenerative diseases can be challenging depending on the severity of the phenotype of a specific model at a given age. Several diseases, most prominently PD, show strong motor behavior (locomotion) deficits, both in patients and in animal models. One of the four key symptoms in PD is bradykinesia, which progresses with aging and manifests in severe gait impairments already in early stages of PD9. Studies of the acute PD model, rodents treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP), have already used VPI gait analysis10,11,12. However, given the acute nature of this model, these studies do not address the age-related progression of motor deficits. Several recent studies have conducted gait analysis in aged mice with neurodegenerative changes, for example13,14,15, emphasizing the relevance of understanding the disease progression with advancing age.
In addition to motor deficits, animal models of neurodegenerative diseases often have difficulties focusing on the examination tasks and show prominent cognitive impairments, in particular with advancing age. Such a phenotype can influence the result of motor behavior tests. Namely, one of the most widely used tests to examine motor deficits, the rotarod test16, relies on cognition, attention, and stress17,18. While the willingness to walk on a motorized treadmill also depends on these factors, the recorded read-out is running, which is a more standardized feature and far less influenced by altered cognition. Effects of stress and attention may be visible in specific parameters, like swing/stance time for stress, and SL for attention19,20, but not in overall running ability.
The kinematic gait analysis approach further offers the advantage of having options to adjust the challenge for rodent models. The treadmill with adjustable angle and speed allows walking speeds from 0.1 - 99.9 cm/s, so that rodents with severe walking impairments may still be able to run at a slow speed (~10 cm/s). Non-impaired animals can be measured at faster running speeds (30 - 40 cm/s). The observation of whether or not the tested animals are able to run at a certain speed provides a result by itself. Further, the rodent can be additionally challenged to run up an incline, or down a decline, by tilting the treadmill to a desired angle with the help of a goniometer, or by attaching a weighted sled to mouse or rat hind limbs.
In addition to numerous studies of single proteins that are mutated in patients, there is a recent increasing awareness of the links between defective endocytosis process and neurodegeneration13,21,22,23,24,25,26,27,28. Mouse models with reduced levels of endophilin-A (henceforth endophilin), a key player in both clathrin-mediated endocytosis13,21,29,30,31,32,33,45 and clathrin-independent endocytosis34, were found to show neurodegeneration and age-dependent impairments in locomotor activity13,21. Three genes encode the family of endophilin proteins: endophilin 1, endophilin 2, and endophilin 3. Notably, the phenotype resulting from depletion of endophilin proteins varies greatly depending on the number of missing endophilin genes13,21. While triple knock-out (KO) of all endophilin genes is lethal just a few hours after birth, and mice without both endophilin 1 and 2 fail to thrive and die within 3 weeks after birth, single KO for any of the three endophilins shows no obvious phenotype for tested conditions21. Other endophilin mutant genotypes show reduced lifespan and develop motor impairments with increasing age13. For example, endophilin 1KO-2HT-3KO mice display walking alterations and motor coordination problems (as tested by kinematic gait analysis and rotarod) already at 3 months of age, while their littermates, endophilin 1KO-2WT-3KO animals, display a significant reduction in motor coordination only at 15 months of age13. Due to the vast diversity of phenotypes in these models, it is necessary to identify and apply a test that can integrate a variety of challenges corresponding to the animal's motor and cognition abilities, as well as the age. Here, we detail the experimental procedures that capitalize on the kinematic gait analysis to assess the onset and progression of motor impairments in a mouse model that shows neurodegenerative changes (i.e., endophilin mutants). This includes measuring gait parameters at various ages and different severities of locomotion impairments.
All animal experiments reported here are conducted according to the European Guidelines for animal welfare (2010/63/EU) with approval by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES), registration number 14/1701.
1. Study Design
2. Video Recording
NOTE: To illustrate the use of kinematic gait analysis, here a commercially available imaging system with its accompanying imaging and analysis software (see the Table of Materials) are used.
3. Video Processing
4. Gait Analysis
5. Troubleshooting
NOTE: Some animals, especially mouse models with an anxiety phenotype, may have difficulties to perform even a simple task like running on a treadmill. The following are steps that can be taken to lower anxiety levels and encourage running.
To illustrate the use of kinematic gait analysis, we have performed gait analysis on WT C57BL/6J mice with advancing age, as well as several endophilin mutant lines, using commercially available instrumentation and software (please refer to the Table of Materials). In this setup, a high-speed camera under a transparent treadmill records the running of a mouse (Figure 1A). The software then recognizes the contrast between the red colored paws ...
Studying the motor coordination is a useful approach in the characterization of models of neurodegenerative diseases, especially for diseases like PD in which motor coordination is severely affected. With the help of a kinematic gait analysis functional assay, we can identify subtle changes in the gait of animals at the onset of locomotion problems, or in models with weak neurodegeneration and hence relatively modest phenotype. Given the wide range of phenotypes in various models of neurodegenerative diseases that encomp...
The authors declare no competing financial interests.
We thank animal caretakers at the ENI's Animal facility for help with breeding, and Dr. Nuno Raimundo for useful comments on the manuscript. I.M. is supported by the grants from the German Research Foundation (DFG) through the collaborative research center SFB-889 (project A8) and SFB-1190 (project P02), and the Emmy Noether Young Investigator Award (1702/1). C.M.R. is supported by the fellowship from the Göttingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB).
Name | Company | Catalog Number | Comments |
DigiGait | Mouse Specifics, Inc., Framingham, Massachusetts, USA | DigiGait Imager and Analysis Software are included with the hardware | |
non-transparent blanket or dark cloth | cover the test chamber to reduce the animal's feeling of exposure/stress | ||
balance | e.g. Satorius | balance with 0.1 g accuracy and a maximum load of at least 100 g | |
red finger paint | e.g. Kreul or Staedtler | for increasing the contrast between paws and animal’s body | |
small paint brush | soft brush to apply finger paint to the animal paws | ||
diluted detergent | for cleaning | ||
disinfectant, e.g. Meliseptol or 70% ethanol | e.g. B.Braun | for desinfection |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved